Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes of Stockholders??? Deficit (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes of Stockholders’ Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022   47,250,771    
Beginning Balance at Dec. 31, 2022 $ 27,819 $ 4,725 $ 68,128,196 $ (68,105,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,214,863   1,214,863  
Exercise of warrants 0      
Exercise of stock options (in shares)   30,504    
Exercise of stock options 59,190 $ 3 59,187  
Net income (loss) (14,138,665)     (14,138,665)
Ending Balance (in shares) at Mar. 31, 2023   47,281,275    
Ending Balance at Mar. 31, 2023 (12,836,793) $ 4,728 69,402,246 (82,243,767)
Beginning Balance (in shares) at Dec. 31, 2023   50,035,824    
Beginning Balance at Dec. 31, 2023 (41,786,850) $ 5,004 76,999,849 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 530,655   530,655  
Vesting of RSUs (in shares)   1,581,201    
Vesting of RSUs 0 $ 158 (158)  
Exercise of warrants (in shares)   5,700,000    
Exercise of warrants 1,339,654 $ 570 1,339,084  
Net income (loss) 413,612     413,612
Ending Balance (in shares) at Mar. 31, 2024   57,317,025    
Ending Balance at Mar. 31, 2024 $ (39,502,929) $ 5,732 $ 78,869,430 $ (118,378,091)